While the IGF pathway as a system has recently been shown to be significantly associated with PCa mortality (Cao et al., 2014), there was no specific correlation between elevated IGF2 and tumor stage, Gleason score, or PSA levels. This evidence concerns the gene IGF1 and neoplasm.